7/7/2009

Eli Lilly and Co.'s cancer drug Alimta gained FDA clearance as a maintenance therapy for advanced non-small-cell lung cancer. The blockbuster drug is approved as a standalone or combined treatment for advanced forms of lung cancer and mesothelioma.

Related Summaries